Vertex Pharmaceuticals Incorporated ( VRTX) - Key Metrics

VRTX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $13.13 $4.33 $4.43 $3.99
2026Q1 $11.75 $4.06 $5.62 $5.10
2025Q4 $12.71 $4.69 $1.96 $1.37
2025Q3 $12.04 $4.24 $4.86 $4.46
2025Q2 $11.55 $4.02 $4.18 $3.61

VRTX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 28.68
2026Q1 0% 27.50
2025Q4 0% 24.17
2025Q3 0% 23.09
2025Q2 0% 27.69

VRTX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.80% 0%
2026Q1 1.14% 0%
2025Q4 0.30% 0%
2025Q3 1.14% 0%
2025Q2 0.81% 0%

VRTX

Price: $510.08

52 week price:
400.86
560.25

Payout Ratio Range:
0.37%
24.93%

Earnings Per Share: 17.16 USD

P/E Ratio: 28.91

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.1 million

Ebitda: 142.2 million

Market Capitalization: 127.5 billion

Links: